EP1888548
Quinoline derivative for the treatment of retinal diseases
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
26.5.2006EP published:
22.8.2012EP application number:
06760388.6
EPO information:
European Patent Register
Max expiry date:
25.5.2026
Title:
Quinoline derivative for the treatment of retinal diseases
Timeline
Today
26.5.2006EP application
22.8.2012EP Publication
Owner
Name:
Aldexa Therapeutics, Inc.Address:
15 New England Executive Park, 01803, Burlington, MA, US
Inventor
Name:
JORDAN, Thomas, A.Address:
Boston, MA, US
Name:
DOWLING, John, E.Address:
Boston, MA, US
Name:
CHABALA, John, CliffordAddress:
Scotch Plains, New Jersey, US
Priority
Number:
685460 PDate:
26.5.2005Country:
US
Number:
723577 PDate:
4.10.2005Country:
US
Classification
Categories:
C07D 277/56, C07D 277/40, A61K 31/435, A61K 31/41, C07C 211/26, C07C 215/68, C07C 229/60, C07C 229/56, C07D 215/38